Claudio Avila is the founder of Atea Pharmaceuticals. Atea Pharmaceuticals has raised $500M in total funding. Latest round: IPO. Based in Boston, MA.
Claudio Avila, MB, BS, Ph.D., is a senior executive at Atea Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing oral antiviral therapies for life-threatening viral diseases. He brings expertise in antiviral drug development and virology to his role.
Full founder directory · Investor directory · Company funding database · Fundraising library